The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $105.55

Today's change-0.16 -0.15%
Updated July 2 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $105.55

Today's change-0.16 -0.15%
Updated July 2 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp down (U.S.)$0.16

CVS Health Corp closed lower Thursday, dropping (U.S.)$0.16 or 0.15% to (U.S.)$105.55. Over the last five days, shares have gained 0.51% and are currently 1.24% off of the 52-week high. Shares have outperformed the S&P 500 by 33.25% during the last year.

Key company metrics

  • Open(U.S.) $105.83
  • Previous close(U.S.) $105.71
  • High(U.S.) $106.22
  • Low(U.S.) $105.36
  • Bid / Ask-- / --
  • YTD % change+9.59%
  • Volume2,509,665
  • Average volume (10-day)5,381,544
  • Average volume (1-month)4,397,115
  • Average volume (3-month)4,422,883
  • 52-week range(U.S.) $74.69 to (U.S.) $106.88
  • Beta0.98
  • Trailing P/E25.75×
  • P/E 1 year forward20.43×
  • Forward PEG1.33×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.33%
  • Trailing EPS(U.S.) $4.10
Updated July 2 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.31%

Based on its net profit margin of 3.31%, CVS Health Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue36,33237,05535,02134,602
Total other revenue--------
Total revenue36,33237,05535,02134,602
Gross profit6,1646,6336,4686,324
Total cost of revenue30,16830,42228,55328,278
Total operating expense34,20034,73433,29632,394
Selling / general / administrative4,0324,3124,2224,116
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0521--
Other operating expenses, total--------
Operating income2,1322,3211,7252,208
Interest income (expense), net non-operating-137-135-158-161
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9982,1901,5722,050
Income after tax1,2211,3229481,246
Income tax, total777868624804
Net income1,2211,3219481,246
Total adjustments to net income--------
Net income before extra. items1,2211,3229481,246
Minority interest--0----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2211,3229481,246
Inc. avail. to common incl. extra. items1,2211,3219481,246
Diluted net income1,2211,3219481,246
Dilution adjustment--------
Diluted weighted average shares1,1361,1511,1641,174
Diluted EPS excluding extraordinary itemsvalue per share1.071.150.811.06
Dividends per sharevalue per share0.350.280.280.28
Diluted normalized EPSvalue per share1.071.151.081.06